Streetbeat News

Price Targets

KO

In the last quarter, Coca-Cola (NYSE:KO) received 2 bullish, 4 somewhat bullish, and 2 indifferent analyst ratings. The average 12-month price target for the stock is $69.38, up 0.98% from the previous average of $68.71.

Portfolio Pulse from Benzinga Insights

June 07, 2023 | 3:06 pm

DLR

Deutsche Bank analyst Matthew Niknam maintains a Buy rating on Digital Realty Trust (NYSE:DLR) and lowers the price target from $113 to $112.

Portfolio Pulse from jenniferd'souza@benzinga.com

June 07, 2023 | 3:06 pm

HQY

Deutsche Bank analyst George Hill maintains a Buy rating on HealthEquity (NASDAQ:HQY) and raises the price target from $69 to $71.

Portfolio Pulse from jenniferd'souza@benzinga.com

June 07, 2023 | 3:03 pm

IRTC

In the last 3 months, 9 analysts have offered 12-month price targets for iRhythm Technologies (NASDAQ:IRTC), with an average price target of $145.78. The average price target has increased by 6.32% over the past month.

Portfolio Pulse from Benzinga Insights

June 07, 2023 | 3:03 pm

IONS

Over the past 3 months, 10 analysts have published their opinion on Ionis Pharmaceuticals (NASDAQ:IONS) stock, with an average 12-month price target of $53.7, up 6.34% from the previous average of $50.50. The ratings include 3 bullish, 3 somewhat bullish, 3 indifferent, and 1 somewhat bearish.

Portfolio Pulse from Benzinga Insights

June 07, 2023 | 3:02 pm

CIEN

Northland Capital Markets analyst Tim Savageaux maintains a Market Perform rating on Ciena (NYSE:CIEN) and lowers the price target from $45 to $41.

Portfolio Pulse from jenniferd'souza@benzinga.com

June 07, 2023 | 3:01 pm

BWA

Goldman Sachs analyst Kash Rangan maintains a Neutral rating on BorgWarner (NYSE:BWA) and raises the price target from $45 to $51.

Portfolio Pulse from jenniferd'souza@benzinga.com

June 07, 2023 | 2:59 pm

YMAB

Canaccord Genuity analyst William Plovanic has reiterated a Buy rating on Y-mAbs Therapeutics (NASDAQ:YMAB) and maintained a $21 price target.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 2:35 pm

IRTC

Canaccord Genuity analyst William Plovanic has reiterated a Buy rating on iRhythm Technologies (NASDAQ:IRTC) and maintained a $153 price target.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 2:33 pm

DT

Canaccord Genuity analyst Kingsley Crane has reiterated a Buy rating on Dynatrace (NYSE:DT) and maintained a $53 price target.

Portfolio Pulse from richadhand@benzinga.com

June 07, 2023 | 2:32 pm